Furthermore, in a subtype analysis of basal-like breast cancer, which includes a majority of TNBCs, we found that neither IGF1R nor IR were associated with a worse outcome (overall survival, relapse free survival or distant disease free survival) using in-silico analysis. The gene discussed is INSR; the disease is breast carcinoma.